Lack of cardioprotection from subcutaneously and preischemic administered Liraglutide in a closed chest porcine ischemia reperfusion model

BACKGROUND: Glucagon-like peptide 1 (GLP1) analogues are promising new treatment options for patients with type 2 diabetes, but may have both potentially beneficial and harmful cardiovascular effects. This may also be the case for the analogues of GLP1 for clinical use. The present study examined th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Jens, Mortensen, Ulrik M, Schmidt, Morten, Nielsen, Peter Haubjerg, Nielsen, Torsten Toftegaard, Maeng, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728095/
https://www.ncbi.nlm.nih.gov/pubmed/19627582
http://dx.doi.org/10.1186/1471-2261-9-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728095/
https://www.ncbi.nlm.nih.gov/pubmed/19627582
http://dx.doi.org/10.1186/1471-2261-9-31

Ejemplares similares